Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:anticoagulant |
| gptkbp:activeIngredient |
gptkb:enoxaparin
|
| gptkbp:approvedBy |
1993
|
| gptkbp:ATCCode |
B01AB05
|
| gptkbp:availableOn |
pre-filled syringe
multi-dose vial |
| gptkbp:chemicalClass |
low molecular weight heparin
|
| gptkbp:contraindication |
history of heparin-induced thrombocytopenia
active major bleeding |
| https://www.w3.org/2000/01/rdf-schema#label |
Clexane
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:mechanismOfAction |
inhibits factor Xa
inhibits thrombin formation |
| gptkbp:pregnancyCategory |
B1 (Australia)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
bleeding
injection site reaction thrombocytopenia |
| gptkbp:usedFor |
gptkb:acute_coronary_syndrome
treatment of deep vein thrombosis treatment of pulmonary embolism prevention of deep vein thrombosis prevention of pulmonary embolism |
| gptkbp:bfsParent |
gptkb:Sanofi
|
| gptkbp:bfsLayer |
5
|